Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q74639732)
Watch
English
Pharmacokinetics of anticancer agents in patients with impaired liver function
scientific article published on 01 January 1998
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9624235
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624235%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
review article
1 reference
stated in
Europe PubMed Central
title
Pharmacokinetics of anticancer agents in patients with impaired liver function
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9624235
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624235%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
main subject
pharmacokinetics
1 reference
based on heuristic
inferred from title
author
Massimo Zucchetti
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9624235
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624235%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
Elisabetta Munzone
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9624235
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624235%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
Maurizio D'Incalci
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9624235
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624235%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
author name string
M G Donelli
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9624235
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624235%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
A Crosignani
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9624235
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624235%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
publication date
1 January 1998
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9624235
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624235%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
published in
European Journal of Cancer
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9624235
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624235%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
volume
34
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9624235
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624235%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
issue
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9624235
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624235%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
page(s)
33-46
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9624235
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624235%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
cites work
Altered protein binding of etoposide in patients with cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Drug monitoring of etoposide (VP16-213). Correlation of pharmacokinetic parameters to clinical and biochemical data from patients receiving etoposide
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interpatient and intrapatient variability in vinblastine pharmacokinetics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of human renal and hepatic disease on the pharmacokinetics of anticancer drugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effects of impaired liver function on the elimination of antineoplastic agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Analytic aspects and clinical interpretation of serum bilirubins
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of liver disease and food on plasma MEGX concentrations
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatic extraction of adriamycin in patients with hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics of adriamycin, adriamycinol, and antipyrine in patients with moderate tumor involvement of the liver
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute doxorubicin toxicity. Relationship to pretreatment liver function, response, and pharmacokinetics in patients with acute nonlymphocytic leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics and pharmacodynamics of doxorubicin in patients with small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical efficacy and toxicity of standard dose adriamycin in hyperbilirubinaemic patients with hepatocellular carcinoma: relation to liver tests and pharmacokinetic parameters
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized study of epirubicin at four different dose levels in advanced breast cancer. Feasibility of myelotoxicity prediction through single blood-sample measurement.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A pharmacokinetic and pharmacodynamic study of the new anthracycline pirarubicin in breast cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Human pharmacokinetics of N-L-leucyl-doxorubicin, a new anthracycline derivative, and its correlation with clinical toxicities
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics of oral idarubicin in breast cancer patients with reference to antitumor activity and side effects
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics and pharmacodynamics of long-term continuous-infusion doxorubicin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Limited sampling models for doxorubicin pharmacokinetics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cellular and plasma pharmacokinetics of weekly 20-mg 4'-epi-adriamycin bolus injection in patients with advanced breast carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Metabolism of epirubicin to glucuronides: relationship to the pharmacodynamics of the drug.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multiple-dose pharmacokinetics of epirubicin at four different dose levels: studies in patients with metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical pharmacokinetics of epirubicin: the importance of liver biochemistry tests
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epirubicin and doxorubicin comparative metabolism and pharmacokinetics. A cross-over study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics of 4-demethoxydaunorubicin in cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Idarubicin metabolism and pharmacokinetics after intravenous and oral administration in cancer patients: a crossover study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low dose oral administration of 4-demethoxydaunorubicin (idarubicin) in advanced cancer patients. A pharmacokinetic study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacology of mitoxantrone in cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The clinical pharmacology of mitozantrone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics of mitoxantrone in humans following single-agent infusion or intra-arterial injection therapy or combined-agent infusion therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fluorouracil therapy in patients with carcinoma of the large bowel: a pharmacokinetic comparison of various rates and routes of administration
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatic conversion of 1-(tetrahydro-2-furanyl)-5-fluorouracil into 5-fluorouracil in patients with hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
No effect of dose, hepatic function, or nutritional status on 5-FU clearance following continuous (5-day), 5-FU infusion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clearance of continuously infused 5-fluorouracil in adults having lung or gastrointestinal carcinoma with or without hepatic metastases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Kinetic modeling of in vivo--nuclear magnetic resonance spectroscopy data: 5-fluorouracil in liver and liver tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Use of the automatic interaction detector method to identify patient characteristics related to methotrexate clearance
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Plasma and urine levels of methotrexate and 7-hydroxymethotrexate in children with ALL during maintenance therapy with weekly oral methotrexate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of liver failure on the pharmacokinetics of cyclophosphamide
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vincristine neurotoxicity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Biliary excretion of vincristine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Can severe vincristine neurotoxicity be prevented?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The correlation of vinblastine pharmacokinetics to toxicity in testicular cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics of vinorelbine in patients with liver metastases.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Relationships between the structure of taxol analogs and their antimitotic activity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase I trial of taxol given by a 6-hour intravenous infusion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Population pharmacokinetics of docetaxel during phase I studies using nonlinear mixed-effect modeling and nonparametric maximum-likelihood estimation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The clinical pharmacology of etoposide and teniposide
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical pharmacodynamics of continuous infusion teniposide: systemic exposure as a determinant of response in a phase I trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Etoposide pharmacokinetics in patients with normal and abnormal organ function
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Etoposide kinetics in patients with obstructive jaundice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predicting etoposide toxicity: relationship to organ function and protein binding
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Etoposide protein binding in cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacodynamics of prolonged oral etoposide in patients with advanced non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics of teniposide (VM 26) after IV administration in serum and malignant ascites of patients with ovarian carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liver metastases from breast cancer: the relationship between clinical, biochemical and pathological features and survival
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900340-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0959-8049(97)00340-7
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9624235
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624235%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
PubMed publication ID
9624235
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9624235
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624235%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit